PorTal Access Announces FDA Clearance of FLEXI-PORT™ family of implantable vascular access ports
MIAMI, June 22, 2026 /PRNewswire/ -- PorTal Access, Inc., an innovative medical device company advancing vascular access technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the FLEXI-PORT™ family of implantable vascular access ports....
MIAMI, June 22, 2026 /PRNewswire/ -- PorTal Access, Inc., an innovative medical device company advancing vascular access technologies, today announced that the U.S. Food and Drug Administration (FDA) has granted clearance for the FLEXI-PORT™ family of implantable vascular access ports....
Summary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.